Two first-in-human, open-label, phase I dose-escalation safety trials of MEDI-528, a monoclonal antibody against interleukin-9, in healthy adult volunteers (Q47790377)
Jump to navigation
Jump to search
scientific article published in April 2009
Language | Label | Description | Also known as |
---|---|---|---|
English | Two first-in-human, open-label, phase I dose-escalation safety trials of MEDI-528, a monoclonal antibody against interleukin-9, in healthy adult volunteers |
scientific article published in April 2009 |
Statements
1 reference
Two first-in-human, open-label, phase I dose-escalation safety trials of MEDI-528, a monoclonal antibody against interleukin-9, in healthy adult volunteers (English)
1 reference
Barbara White
1 reference
Francisco Leon
1 reference
Wendy White
1 reference
Gabriel Robbie
1 reference
1 April 2009
1 reference
31
1 reference
4
1 reference
728-740
1 reference